Reverse DCF
What growth does the market imply for GPTHEALTH?
Working backwards from the current price to find the FCF growth assumption baked in.
very aggressive
23.6% implied annual FCF growth
The market is pricing in exceptional growth that only a handful of companies sustain for a decade. For context, this company has historically grown at 3.6%. High execution risk.
Current Price
₹136
Historical Growth
3.6%
FCF Yield
1.56%
Price / FCF
64.1x
Plain English
To justify today's price of $136.45, GPTHEALTH.NS needs to grow its free cash flow at 23.6% per year for the next 10 years. That is 20.0% faster than its historical growth rate of 3.6%. At its historical growth rate, the stock cannot justify its current price within a 20-year horizon. The market is pricing in a step-change in performance.
Adjust Assumptions
Growth Scenarios
What the stock is worth at different growth assumptions
| Scenario | FCF Growth | Implied IV | MoS vs Price |
|---|---|---|---|
| Historical | 3.6% | ₹26 | -80.7% |
| GDP rate | 10.0% | ₹45 | -66.7% |
| Half implied | 11.8% | ₹53 | -61.3% |
| Implied | 23.6% | ₹136 | -0.1% |
See full DCF analysis
Bear/base/bull scenarios, sensitivity heatmap, Monte Carlo, and more.
Run Full Analysis →This is an analytical tool, not investment advice. Implied growth is a mathematical inversion of the DCF model and depends on WACC and terminal growth assumptions. YieldIQ is not registered with SEBI as an investment adviser.